DP

DP Aircraft I Limited

Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.

Overview

Corporate Details

ISIN(s):
GG00BBP6HP33
LEI:
213800IJ1Q9HI499AE41
Country:
Guernsey
Address:
EAST WING, GY1 3PP ST PETER PORT
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DP Aircraft I Limited is an investment holding company that specializes in the acquisition, leasing, and subsequent sale of aircraft. The company's investment objective is to generate income and capital returns for its shareholders. Its portfolio is focused on Boeing 787-8 aircraft, which it leases to commercial airlines. The company holds its aircraft assets through its subsidiaries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 17:22
Interim Report
Interim Report and Accounts
English 1.3 MB
2025-09-29 13:55
Interim Report
Interim Report and Accounts
English 646.7 KB
2025-03-27 16:51
Regulatory News Service
New Lease Agreements with LOT Polish Airlines
English 13.2 KB

Automate Your Workflow. Get a real-time feed of all DP Aircraft I Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DP Aircraft I Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.